Delcath Systems, Inc. (DCTH) Insider Trading
Directors, officers and holders of more than 10% of DCTH report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 54 transactions on file: 4 with code P, 0 with code S and 46 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | Rosalind Advisors, Inc. | Director | C Conversion | 3,627 | Not measured | Not measured |
| Oct 13, 2026 | Rosalind Advisors, Inc. | Director | C Conversion | 36 | Not measured | Not measured |
| Oct 13, 2026 | Rosalind Advisors, Inc. | Director | J Other | 27,502 | Not measured | Not measured |
| May 13, 2026 | CZEREPAK ELIZABETH | Director | A Award | 22,500 | Not measured | Not measured |
| May 13, 2026 | Sylvester John Richard | Director | A Award | 22,500 | Not measured | Not measured |
| May 13, 2026 | Martell Bridget A | Director | A Award | 22,500 | Not measured | Not measured |
| May 13, 2026 | SALAMON STEVEN A J | Director | A Award | 22,500 | Not measured | Not measured |
| May 13, 2026 | Aharon Gil | Director | A Award | 22,500 | Not measured | Not measured |
| Mar 6, 2026 | Pennell Sandra | Chief Financial Officer | P Purchase | 5,533 | $9.04 | $50,018 |
| Mar 2, 2026 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | P Purchase | 11,200 | $8.96 | $100,309 |
| Feb 17, 2026 | Hoffman David L. | GEN'L COUNSEL, CCO & SECY | A Award | 56,500 | Not measured | Not measured |
| Feb 17, 2026 | Muir Kevin | GM INTERVENTIONAL ONCOLOGY | A Award | 28,250 | Not measured | Not measured |
| Feb 17, 2026 | Pennell Sandra | Chief Financial Officer | A Award | 56,500 | Not measured | Not measured |
| Feb 17, 2026 | Pennell Sandra | Chief Financial Officer | A Award | 28,250 | Not measured | Not measured |
| Feb 17, 2026 | Vukovic Vojo | CHIEF MEDICAL OFFICER | A Award | 56,500 | Not measured | Not measured |
| Feb 17, 2026 | Vukovic Vojo | CHIEF MEDICAL OFFICER | A Award | 28,250 | Not measured | Not measured |
| Feb 17, 2026 | Rook Martha S. | CHIEF OPERATING OFFICER | A Award | 56,500 | Not measured | Not measured |
| Feb 17, 2026 | Rook Martha S. | CHIEF OPERATING OFFICER | A Award | 28,250 | Not measured | Not measured |
| Feb 17, 2026 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | A Award | 195,000 | Not measured | Not measured |
| Feb 17, 2026 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | A Award | 97,500 | Not measured | Not measured |
| Feb 17, 2026 | Hoffman David L. | GEN'L COUNSEL, CCO & SECY | A Award | 28,250 | Not measured | Not measured |
| Feb 17, 2026 | Muir Kevin | GM INTERVENTIONAL ONCOLOGY | A Award | 56,500 | Not measured | Not measured |
| Nov 21, 2025 | Sylvester John Richard | Director | P Purchase | 4,386 | $8.89 | $38,992 |
| Nov 11, 2025 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | P Purchase | 11,500 | $8.53 | $98,049 |
| Jun 12, 2025 | Vukovic Vojo | CHIEF MEDICAL OFFICER | M Exercise | 42,000 | Not measured | Not measured |
| Jun 12, 2025 | Vukovic Vojo | CHIEF MEDICAL OFFICER | M Exercise | 42,000 | $4.78 | $200,760 |
| May 15, 2025 | Sylvester John Richard | Director | A Award | 22,500 | Not measured | Not measured |
| May 15, 2025 | SALAMON STEVEN A J | Director | A Award | 22,500 | Not measured | Not measured |
| May 15, 2025 | Aharon Gil | Director | A Award | 22,500 | Not measured | Not measured |
| May 15, 2025 | CZEREPAK ELIZABETH | Director | A Award | 22,500 | Not measured | Not measured |
| May 15, 2025 | Martell Bridget A | Director | A Award | 22,500 | Not measured | Not measured |
| May 5, 2025 | Rosalind Advisors, Inc. | Director | X In-the-Money | 400,000 | $10.00 | $4,000,000 |
| May 5, 2025 | Aharon Gil | Director | X In-the-Money | 400,000 | $10.00 | $4,000,000 |
| May 5, 2025 | SALAMON STEVEN A J | Director | X In-the-Money | 400,000 | $10.00 | $4,000,000 |
| Feb 7, 2025 | Vukovic Vojo | CHIEF MEDICAL OFFICER | A Award | 113,000 | Not measured | Not measured |
| Feb 7, 2025 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | A Award | 390,000 | Not measured | Not measured |
| Feb 7, 2025 | Muir Kevin | GM INTERVENTIONAL ONCOLOGY | A Award | 113,000 | Not measured | Not measured |
| Feb 7, 2025 | Rook Martha S. | CHIEF OPERATING OFFICER | A Award | 113,000 | Not measured | Not measured |
| Feb 7, 2025 | Pennell Sandra | Chief Financial Officer | A Award | 113,000 | Not measured | Not measured |
| Feb 7, 2025 | Hoffman David L. | GEN'L COUNSEL, CCO & SECY | A Award | 113,000 | Not measured | Not measured |
| Dec 24, 2024 | Rosalind Advisors, Inc. | Director | M Exercise | 603,954 | $9.99 | $6,033,500 |
| Dec 24, 2024 | Rosalind Advisors, Inc. | Director | C Conversion | 250,000 | $10.00 | $2,500,000 |
| Dec 24, 2024 | Aharon Gil | Director | C Conversion | 250,000 | $10.00 | $2,500,000 |
| Dec 24, 2024 | SALAMON STEVEN A J | Director | C Conversion | 250,000 | $10.00 | $2,500,000 |
| Dec 24, 2024 | SALAMON STEVEN A J | Director | M Exercise | 603,954 | $9.99 | $6,033,500 |
| Dec 24, 2024 | Aharon Gil | Director | M Exercise | 603,954 | $9.99 | $6,033,500 |
| Oct 30, 2024 | SALAMON STEVEN A J | Director | M Exercise | 500 | $1000.00 | $500,000 |
| Oct 30, 2024 | Aharon Gil | Director | M Exercise | 500 | $1000.00 | $500,000 |
| Oct 30, 2024 | Aharon Gil | Director | H Expiration (Short) | 0 | Not measured | Not measured |
| Oct 30, 2024 | Rosalind Advisors, Inc. | Director | M Exercise | 500 | $1000.00 | $500,000 |
The full Form 4 history is on the DCTH company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.